Your institution may have access to this item. Find your institution then sign in to continue.
Title
Sirna Therapeutics granted patents on RNA interference technology.
Abstract
The article reports that Sirna Therapeutics Inc. was granted two major patents by the British Patent Office for its RNA interference technology. The first patent covers the chemical and structural modifications of short interfering RNAs necessary for the creation of viable siRNA-based therapeutics, while the second covers chemically modified siRNAs targeting a receptor of VEGF.